News + Filings Transactions
|
Gengos Andrew
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/07/2023 | Athira Pharma, Inc. | ATHA | Purchase | Common Stock | 11.7k | $3.44 | $40.3k | | 06/07/2023 |
| 06/07/2023 | Athira Pharma, Inc. | ATHA | Purchase | Common Stock | 2.9k | $3.40 | $9.7k | | 06/07/2023 |
| 06/07/2023 | Athira Pharma, Inc. | ATHA | Purchase | Common Stock | 422 | $3.36 | $1.4k | | 06/07/2023 |
| 06/05/2023 | Athira Pharma, Inc. | ATHA | Purchase | Common Stock | 10k | $3.02 | $30.2k | | 06/02/2023 |
| 06/05/2023 | Athira Pharma, Inc. | ATHA | Purchase | Common Stock | 10k | $3.00 | $30k | | 06/02/2023 |
| 06/05/2023 | Athira Pharma, Inc. | ATHA | Purchase | Common Stock | 10k | $3.00 | $30k | | 06/02/2023 |
| 06/05/2023 | Athira Pharma, Inc. | ATHA | Purchase | Common Stock | 15k | $3.00 | $45k | | 06/02/2023 |
| 06/02/2023 | Athira Pharma, Inc. | ATHA | Purchase | Common Stock | 3.4k | $2.95 | $10.1k | | 06/02/2023 |
| 06/02/2023 | Athira Pharma, Inc. | ATHA | Purchase | Common Stock | 6.6k | $2.86 | $18.8k | | 06/02/2023 |
| 06/02/2023 | Athira Pharma, Inc. | ATHA | Purchase | Common Stock | 10k | $2.75 | $27.5k | | 06/02/2023 |
| 02/22/2022 | Cyteir Therapeutics, Inc. | CYT | Grant | Stock Option (Right to Buy) | 35k | $5.96 | $208.6k | | 02/22/2022 |
| 03/14/2018 | SYNLOGIC, INC. | SYBX | Grant | Stock Option (right to buy) | 10k | $9.95 | $99.5k | | 03/14/2018 |
| 10/31/2017 | SYNLOGIC, INC. | SYBX | Grant | Stock Option (right to buy) | 154k | $14.71 | $2.3M | | 10/31/2017 |
|